STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 136 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$335,035
-8.9%
28,660
+4.7%
0.00%0.0%
Q2 2023$367,853
+6.4%
27,370
+31.2%
0.00%0.0%
Q1 2023$345,859
-10.9%
20,8600.0%0.00%0.0%
Q4 2022$387,996
-79.8%
20,860
-86.1%
0.00%
-80.0%
Q3 2022$1,925,000
-13.0%
150,057
-52.4%
0.01%0.0%
Q2 2022$2,212,000
-9.8%
315,506
+6.6%
0.01%0.0%
Q1 2022$2,453,000
+6.6%
295,899
-12.9%
0.01%
+25.0%
Q4 2021$2,301,000
+9.8%
339,882
-14.0%
0.00%0.0%
Q3 2021$2,095,000
-8.3%
395,346
-0.5%
0.00%0.0%
Q2 2021$2,284,000
-13.8%
397,294
-30.9%
0.00%
-20.0%
Q1 2021$2,649,000
+3913.6%
574,682
+2805.4%
0.01%
Q4 2020$66,000
+11.9%
19,7800.0%0.00%
Q3 2020$59,000
-35.2%
19,7800.0%0.00%
Q2 2020$91,000
+19.7%
19,7800.0%0.00%
Q1 2020$76,000
+1.3%
19,780
-1.1%
0.00%
Q4 2019$75,000
-29.2%
20,0000.0%0.00%
Q3 2019$106,000
+37.7%
20,0000.0%0.00%
Q2 2019$77,000
-24.5%
20,0000.0%0.00%
Q1 2019$102,000
+168.4%
20,0000.0%0.00%
Q4 2018$38,000
-50.0%
20,0000.0%0.00%
Q3 2018$76,000
+22.6%
20,0000.0%0.00%
Q2 2018$62,000
+29.2%
20,0000.0%0.00%
Q1 2018$48,000
-38.5%
20,0000.0%0.00%
Q4 2017$78,000
+56.0%
20,0000.0%0.00%
Q3 2017$50,00020,0000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 213,609$1,446,0002.75%
GABLES CAPITAL MANAGEMENT INC. 449,164$3,041,0001.81%
Prairiewood Capital, LLC 261,403$1,770,0001.40%
ARMISTICE CAPITAL, LLC 9,572,000$64,802,0001.06%
Quantedge Capital Pte Ltd 360,100$2,438,0001.03%
SummerHaven Investment Management, LLC 151,384$1,025,0000.55%
GLOBEFLEX CAPITAL L P 609,030$4,124,0000.42%
EAM Global Investors LLC 347,899$2,355,0000.42%
Lanham O'Dell & Company, Inc. 50,000$339,0000.27%
EAM Investors, LLC 239,071$1,619,0000.27%
View complete list of CATALYST PHARMACEUTICALS INC shareholders